157 — Natural Beauty Bio-Technology Balance Sheet
0.000.00%
- HK$1.08bn
- HK$1.21bn
- HK$353.65m
- 30
- 20
- 28
- 11
Annual balance sheet for Natural Beauty Bio-Technology, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 162 | 193 | 169 | 167 | 117 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 116 | 116 | 79.2 | 83.2 | 72.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 400 | 450 | 365 | 343 | 289 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 370 | 417 | 238 | 271 | 274 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 832 | 930 | 872 | 872 | 773 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 205 | 238 | 251 | 283 | 188 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 221 | 273 | 275 | 298 | 325 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 611 | 658 | 597 | 575 | 448 |
| Total Liabilities & Shareholders' Equity | 832 | 930 | 872 | 872 | 773 |
| Total Common Shares Outstanding |